Press Releases Keyword Search Year None2025202420232022202120202019201820172016201520142013 Jan 16, 2025 Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale Jan 09, 2025 Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates
Jan 16, 2025 Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale
Jan 09, 2025 Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates